OSdlbcl: An online consensus survival analysis web server based on gene expression profiles of diffuse large B‐cell lymphoma
出版年份 2020 全文链接
标题
OSdlbcl: An online consensus survival analysis web server based on gene expression profiles of diffuse large B‐cell lymphoma
作者
关键词
-
出版物
Cancer Medicine
Volume 9, Issue 5, Pages 1790-1797
出版商
Wiley
发表日期
2020-01-10
DOI
10.1002/cam4.2829
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Expression of NOTCH3 exon 16 differentiates Diffuse Large B-cell Lymphoma into molecular subtypes and is associated with prognosis
- (2019) Ditte Starberg Jespersen et al. Scientific Reports
- High KRT8 Expression Independently Predicts Poor Prognosis for Lung Adenocarcinoma Patients
- (2019) Longxiang Xie et al. Genes
- OSlms: A Web Server to Evaluate the Prognostic Value of Genes in Leiomyosarcoma
- (2019) Qiang Wang et al. Frontiers in Oncology
- Low Expression and Promoter Hypermethylation of the Tumour Suppressor SLIT2, are Associated with Adverse Patient Outcomes in Diffuse Large B Cell Lymphoma
- (2019) Ghada Mohamed et al. PATHOLOGY & ONCOLOGY RESEARCH
- OSblca: A Web Server for Investigating Prognostic Biomarkers of Bladder Cancer Patients
- (2019) Guosen Zhang et al. Frontiers in Oncology
- An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
- (2018) Jianfang Liu et al. CELL
- BCL2 expression is associated with a poor prognosis independent of cellular origin in primary central nervous system diffuse large B-cell lymphoma
- (2018) Keishi Makino et al. JOURNAL OF NEURO-ONCOLOGY
- Diffuse large B-cell lymphoma
- (2018) Shaoying Li et al. PATHOLOGY
- Clinical Significance of PTEN Deletion, Mutation, and Loss of PTEN Expression in De Novo Diffuse Large B-Cell Lymphoma
- (2018) Xiaoxiao Wang et al. NEOPLASIA
- CXCL9 promotes the progression of diffuse large B-cell lymphoma through up-regulating β-catenin
- (2018) Cheng Ruiduo et al. BIOMEDICINE & PHARMACOTHERAPY
- Expression profile of translation initiation factor eIF2B5 in diffuse large B-cell lymphoma and its correlation to clinical outcome
- (2018) Julia J. Unterluggauer et al. Blood Cancer Journal
- Clinicopathological characteristics and genomic profile of primary sinonasal tract diffuse large B cell lymphoma (DLBCL) reveals gain at 1q31 and RGS1 encoding protein; high RGS1 immunohistochemical expression associates with poor overall survival in DLBC
- (2017) Joaquim Carreras et al. HISTOPATHOLOGY
- Fbw7 regulates apoptosis in activated B-cell like diffuse large B-cell lymphoma by targeting Stat3 for ubiquitylation and degradation
- (2017) Su Yao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- DNMT1 is predictive of survival and associated with Ki-67 expression in R-CHOP-treated diffuse large B-cell lymphomas
- (2017) Suet Kee Loo et al. PATHOLOGY
- UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
- (2017) Darshan S. Chandrashekar et al. NEOPLASIA
- The hematopoietic oncoprotein FOXP1 promotes tumor cell survival in diffuse large B-cell lymphoma by repressing S1PR2 signaling
- (2016) M. Flori et al. BLOOD
- The 2016 revision of the World Health Organization classification of lymphoid neoplasms
- (2016) S. H. Swerdlow et al. BLOOD
- Sphingosine-1-phosphate receptor 1 as a prognostic biomarker and therapeutic target for patients with primary testicular diffuse large B-cell lymphoma
- (2016) Risa Koresawa et al. BRITISH JOURNAL OF HAEMATOLOGY
- Diffuse Large B-cell lymphoma: Prognostic markers and their impact on therapy
- (2016) Muhammad O. Jamil et al. Expert Review of Hematology
- Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients
- (2016) A. Marcell Szász et al. Oncotarget
- CD43 expression in diffuse large B-cell lymphoma, not otherwise specified: CD43 is a marker of adverse prognosis
- (2015) Xiao-Bo Ma et al. HUMAN PATHOLOGY
- Multiparameter analysis of homogeneously R-CHOP-treated diffuse large B cell lymphomas identifies CD5 and FOXP1 as relevant prognostic biomarkers: report of the prospective SAKK 38/07 study
- (2015) Alexandar Tzankov et al. Journal of Hematology & Oncology
- Occurrence and prognostic relevance of CD30 expression in post-transplant lymphoproliferative disorders
- (2015) Maja Ølholm Vase et al. LEUKEMIA & LYMPHOMA
- Serum soluble LR11, a novel tumor derived biomarker associated with the outcome of patients with diffuse large B-cell lymphoma
- (2015) Chikako Ohwada et al. LEUKEMIA & LYMPHOMA
- Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphoma
- (2015) Jiayu Chen et al. Oncotarget
- Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue
- (2014) D. W. Scott et al. BLOOD
- Characterization of genomic imbalances in diffuse large B-cell lymphoma by detailed SNP-chip analysis
- (2014) René Scholtysik et al. INTERNATIONAL JOURNAL OF CANCER
- Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
- (2014) Bruce D. Cheson et al. JOURNAL OF CLINICAL ONCOLOGY
- SPIB and BATF provide alternate determinants of IRF4 occupancy in diffuse large B-cell lymphoma linked to disease heterogeneity
- (2014) Matthew A. Care et al. NUCLEIC ACIDS RESEARCH
- SYK Inhibition Modulates Distinct PI3K/AKT- Dependent Survival Pathways and Cholesterol Biosynthesis in Diffuse Large B Cell Lymphomas
- (2013) Linfeng Chen et al. CANCER CELL
- SurvExpress: An Online Biomarker Validation Tool and Database for Cancer Gene Expression Data Using Survival Analysis
- (2013) Raul Aguirre-Gamboa et al. PLoS One
- Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
- (2013) Balázs Győrffy et al. PLoS One
- Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study
- (2012) Z. Y. Xu-Monette et al. BLOOD
- Integrative Analysis Reveals an Outcome-Associated and Targetable Pattern of p53 and Cell Cycle Deregulation in Diffuse Large B Cell Lymphoma
- (2012) Stefano Monti et al. CANCER CELL
- Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients
- (2012) Balázs Győrffy et al. ENDOCRINE-RELATED CANCER
- Concurrent Expression of MYC and BCL2 in Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
- (2012) Nathalie A. Johnson et al. JOURNAL OF CLINICAL ONCOLOGY
- miRNA expression in diffuse large B-cell lymphoma treated with chemoimmunotherapy
- (2011) S. Montes-Moreno et al. BLOOD
- High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy
- (2011) T. M. Cardesa-Salzmann et al. HAEMATOLOGICA
- FOXP1 expression and its clinicopathologic significance in nodal and extranodal diffuse large B-cell lymphoma
- (2010) BaoHua Yu et al. ANNALS OF HEMATOLOGY
- Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab Era
- (2010) Christian Gisselbrecht et al. JOURNAL OF CLINICAL ONCOLOGY
- Relationship between urinary sodium excretion and pioglitazone-induced edema
- (2010) Akinobu Nakamura et al. Journal of Diabetes Investigation
- Stromal Gene Signatures in Large-B-Cell Lymphomas
- (2008) G. Lenz et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started